Suppr超能文献

超越抗生素:探索噬菌体及噬菌体疗法的潜力

Beyond Antibiotics: Exploring the Potential of Bacteriophages and Phage Therapy.

作者信息

Biswas Sudhangshu Kumar, Sumon Md Mehedi Hasan, Ahmed Sabbir, Ruma Rumana Akter, Parvin Anzana, Paul Dipak Kumar, Roy Apurba Kumar, Tang Swee-Seong

机构信息

Bacteriophage Biology and Genomics Lab, Department of Biotechnology and Genetic Engineering, Faculty of Biological Sciences, Islamic University, Kushtia, Bangladesh.

Department of Applied Nutrition and Food Technology, Faculty of Biological Sciences, Islamic University, Kushtia, Bangladesh.

出版信息

Phage (New Rochelle). 2024 Dec 18;5(4):186-202. doi: 10.1089/phage.2024.0005. eCollection 2024 Dec.

Abstract

The escalating global threat of antibiotic resistance has prompted a critical need for innovative approaches to bacterial infection treatment. In terms of management, bacterial-associated disorders have reached a critical point in the world due to the advent of drug-resistant types of bacteria. Nonetheless, continued bacteriophage research presents a promising frontier in the battle against bacterial infections. In this study, we explored the effectiveness of bacteriophage therapy against antibiotic-resistant bacteria. According to our viewpoint, phage therapy could replace antibiotics in terms of safety, efficacy, and specificity. Furthermore, phage therapy offers versatility in administering single phage, phage products, or modified phage against various resistant bacteria. Moreover, Phage cocktails, with their synergistic combinations, showcase a holistic approach, mitigating the risk of resistance and expanding treatment possibilities. Similarly, the synergy between phages and antibiotics holds promise for overcoming antibiotic resistance and forging a path toward more effective and sustainable antimicrobial strategies. The review provides insights into the transformative impact of bacteriophage therapy on current bacterial infection treatment paradigms, its application with methodological challenges and limitations, as well as insights to scientists and policymakers on the best areas to study phages in order to combat antimicrobial resistance.

摘要

全球抗生素耐药性威胁不断升级,促使人们迫切需要创新的细菌感染治疗方法。在管理方面,由于耐药菌的出现,与细菌相关的疾病在全球已达到危急关头。尽管如此,噬菌体研究的持续开展为对抗细菌感染提供了一个充满希望的领域。在本研究中,我们探讨了噬菌体疗法对抗生素耐药菌的有效性。我们认为,噬菌体疗法在安全性、有效性和特异性方面可以替代抗生素。此外,噬菌体疗法在使用单一噬菌体、噬菌体产品或经过改造的噬菌体对抗各种耐药菌方面具有多样性。而且,噬菌体鸡尾酒疗法通过其协同组合,展现了一种整体方法,降低了耐药风险并拓展了治疗可能性。同样,噬菌体与抗生素之间的协同作用有望克服抗生素耐药性,并为制定更有效和可持续的抗菌策略开辟道路。这篇综述深入探讨了噬菌体疗法对当前细菌感染治疗模式的变革性影响、其应用所面临的方法学挑战和局限性,以及为科学家和政策制定者提供的关于研究噬菌体以对抗抗菌药物耐药性的最佳领域的见解。

相似文献

1
Beyond Antibiotics: Exploring the Potential of Bacteriophages and Phage Therapy.
Phage (New Rochelle). 2024 Dec 18;5(4):186-202. doi: 10.1089/phage.2024.0005. eCollection 2024 Dec.
2
and comparative analysis of 79 clinical isolates.
Microbiol Spectr. 2025 Jul;13(7):e0284924. doi: 10.1128/spectrum.02849-24. Epub 2025 May 16.
3
The virulent bacteriophage Henu8 as an antimicrobial synergist against .
Microbiol Spectr. 2025 Jul;13(7):e0163324. doi: 10.1128/spectrum.01633-24. Epub 2025 May 16.
5
AI-Driven Antimicrobial Peptide Discovery: Mining and Generation.
Acc Chem Res. 2025 Jun 17;58(12):1831-1846. doi: 10.1021/acs.accounts.0c00594. Epub 2025 Jun 3.
7
Bacteriophage therapy- a refurbished age-old potential strategy to treat antibiotic and multidrug resistant bacterial infections in future.
Braz J Microbiol. 2024 Sep;55(3):3043-3049. doi: 10.1007/s42770-024-01434-7. Epub 2024 Jul 1.
8
Current Clinical Laboratory Challenges to Widespread Adoption of Phage Therapy in the United States.
Antibiotics (Basel). 2025 May 29;14(6):553. doi: 10.3390/antibiotics14060553.
9
Efficacy of phage therapy in Diabetic Foot Ulcers (DFUs): a systematic review.
BMC Infect Dis. 2025 Jul 1;25(1):819. doi: 10.1186/s12879-025-11258-x.
10
Physicochemical, genomic, and phenotypic characterization of phage BME3.
Microbiol Spectr. 2025 Jul;13(7):e0130124. doi: 10.1128/spectrum.01301-24. Epub 2025 May 22.

引用本文的文献

1
Characterization and antimicrobial activity of a novel lytic phage vB_SmaS_QH16 against : , , and biofilm studies.
Front Cell Infect Microbiol. 2025 Jul 10;15:1610857. doi: 10.3389/fcimb.2025.1610857. eCollection 2025.
2
Addressing the global challenge of bacterial drug resistance: insights, strategies, and future directions.
Front Microbiol. 2025 Feb 24;16:1517772. doi: 10.3389/fmicb.2025.1517772. eCollection 2025.

本文引用的文献

1
Phage-antibiotic combinations in various treatment modalities to manage MRSA infections.
Front Pharmacol. 2024 Apr 9;15:1356179. doi: 10.3389/fphar.2024.1356179. eCollection 2024.
2
Bacteriophage and antibiotic combination therapy for recurrent bacteremia.
mBio. 2024 Mar 13;15(3):e0339623. doi: 10.1128/mbio.03396-23. Epub 2024 Feb 14.
3
Phage therapy as a glimmer of hope in the fight against the recurrence or emergence of surgical site bacterial infections.
Infection. 2024 Apr;52(2):385-402. doi: 10.1007/s15010-024-02178-0. Epub 2024 Feb 2.
4
Isolation and characterization of three novel lytic phages against K54 serotype carbapenem-resistant hypervirulent .
Front Cell Infect Microbiol. 2023 Dec 12;13:1265011. doi: 10.3389/fcimb.2023.1265011. eCollection 2023.
5
Phage Therapy-Challenges, Opportunities and Future Prospects.
Pharmaceuticals (Basel). 2023 Nov 22;16(12):1638. doi: 10.3390/ph16121638.
6
A mechanism-based pathway toward administering highly active N-phage cocktails.
Front Microbiol. 2023 Nov 15;14:1292618. doi: 10.3389/fmicb.2023.1292618. eCollection 2023.
7
Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review.
Pharmaceuticals (Basel). 2023 Nov 15;16(11):1615. doi: 10.3390/ph16111615.
9
Bacteriophages and Their Host Range in Multidrug-Resistant Bacterial Disease Treatment.
Pharmaceuticals (Basel). 2023 Oct 16;16(10):1467. doi: 10.3390/ph16101467.
10
Phages and Nanotechnology: New Insights against Multidrug-Resistant Bacteria.
Biodes Res. 2023 Jan 16;5:0004. doi: 10.34133/bdr.0004. eCollection 2023.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验